2型糖尿病患者HbA1c轨迹与肝脏相关事件风险
基于香港全港新诊断2型糖尿病队列(294,096例)及英国生物银行外部验证,采用时间序列聚类识别HbA1c轨迹。中位随访7.4年,1.2%发生肝脏相关事件。时间加权平均HbA1c更高、HbA1c变异性更大与肝脏相关事件风险升高相关,而HbA1c<7%年数更多与风险降低相关。快速下降轨迹相比轻度下降和上升轨迹风险更低。
要点
- 时间加权平均HbA1c每升高1%,肝脏相关事件风险增加12%(aCSHR 1.12)。
- HbA1c<7%的年数每增加1年,肝脏相关事件风险降低5%(aCSHR 0.95)。
- 基线HbA1c≥9%者快速下降轨迹不增加肝脏相关事件风险(aCSHR 1.05)。
核心结论
- 时间加权平均HbA1c、良好血糖控制累积时间、HbA1c变异性及HbA1c轨迹均与2型糖尿病患者肝脏相关事件相关。
- 快速下降轨迹可能降低高基线HbA1c患者的肝脏相关事件风险。
研究设计与样本
- 香港全港性队列研究,纳入2000年1月至2016年12月新诊断2型糖尿病成人294,096例(平均年龄60.6岁,50.6%男性)。
- 采用时间序列聚类识别HbA1c轨迹,并在英国生物银行进行外部验证。
- 使用原因特异性风险模型估计与肝脏相关事件的关联,以非肝脏相关死亡为竞争风险。
主要发现
- 中位随访7.4年(IQR 4.5-10.0),3,438例(1.2%)发生肝脏相关事件。
- 时间加权平均HbA1c每升高1%,肝脏相关事件风险增加(aCSHR 1.12,95%CI 1.08-1.16,p<0.001)。
- HbA1c<7%的年数每增加1年,肝脏相关事件风险降低(aCSHR 0.95,95%CI 0.93-0.96,p<0.001)。
- 识别出三种轨迹:快速下降(n=43,712;14.9%)、轻度下降(n=114,413;38.9%)、上升(n=135,971;46.2%)。
- 与快速下降相比,轻度下降(aCSHR 1.30,95%CI 1.13-1.50,p<0.001)和上升(aCSHR 1.37,95%CI 1.16-1.61,p<0.001)轨迹风险更高。
关键数值与推荐
- 基线HbA1c≥9%且轻度下降轨迹者相比基线HbA1c<7%且轻度下降轨迹者,肝脏相关事件风险更高(aCSHR 1.27,95%CI 1.08-1.50,p<0.001)。
- 基线HbA1c≥9%且上升轨迹者风险更高(aCSHR 1.84,95%CI 1.45-2.34,p<0.001)。
- 基线HbA1c≥9%且快速下降轨迹者与基线HbA1c<7%且轻度下降轨迹者相比,风险无显著差异(aCSHR 1.05,95%CI 0.90-1.22,p=0.57)。
临床怎么用
- 对2型糖尿病患者应关注长期HbA1c平均水平、达标累积时间及变异性,以评估肝脏相关事件风险。
- 基线HbA1c≥9%的患者,快速下降的HbA1c轨迹可能有助于降低肝脏相关事件风险。
- 轻度下降或上升HbA1c轨迹的患者可能需要更密切监测和更强化干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The relationship between long-term glycaemic control and liver-related events (LREs) in patients with type 2 diabetes mellitus (T2DM) remains unclear. We assessed associations of time-weighted average haemoglobin A1c (HbA1c), time-to-target HbA1c, HbA1c variability, and individual HbA1c trajectories with LREs in T2DM. METHODS: A territory-wide cohort of adults newly diagnosed with T2DM (Jan 2000-Dec 2016) was identified in Hong Kong. HbA1c trajectories were identified via time-series clustering and externally validated in the UK Biobank. Their associations with LREs were estimated in the Hong Kong territory-wide cohort using cause-specific hazards models, with non-liver-related death as a competing risk. RESULTS: Among 294,096 patients identified (mean age, 60.6 years; 50.6% males), 3,438 (1.2%) developed LREs over a median follow-up of 7.4 years (IQR 4.5-10.0). Higher time-weighted average HbA1c (adjusted cause-specific hazard ratio [aCSHR] 1.12 per 1%, 95% CI 1.08-1.16, p <0.001) and greater HbA1c variability were associated with a higher risk of LREs, whereas more years with HbA1c <7% were associated with a lower risk (aCSHR 0.95 per year, 95% CI 0.93-0.96, p <0.001). Three trajectories were identified: rapid decreasing (n = 43,712; 14.9%), mild decreasing (n = 114,413; 38.9%), and increasing (n = 135,971; 46.2%). Compared with rapid decreasing, mild decreasing (aCSHR 1.30, 95% CI 1.13-1.50, p <0.001) and increasing (aCSHR 1.37, 95% CI 1.16-1.61, p <0.001) trajectories conferred higher risks. Compared to patients with baseline HbA1c <7% and a mild decreasing trajectory, those with baseline HbA1c ≥9% and mild decreasing (aCSHR 1.27, 95% CI 1.08-1.50, p <0.001) or increasing (aCSHR 1.84, 95% CI 1.45-2.34, p <0.001) trajectories had higher LRE risks. In contrast, a rapid decreasing trajectory was not associated with a higher risk (aCSHR 1.05, 95% CI 0.90-1.22, p = 0.57). CONCLUSIONS: Time-weighted average HbA1c, cumulative duration of good glycaemic control, HbA1c variability, and HbA1c trajectories were associated with LREs in T2DM. A rapid decreasing trajectory may mitigate LRE risk in patients with high baseline HbA1c. IMPACT AND IMPLICATIONS: The relationship between long-term glycaemic control and liver-related events (LREs) in patients with type 2 diabetes mellitus (T2DM) remains unclear. In this real-world territory-wide cohort study of 294,096 patients with newly diagnosed T2DM, patients with higher average HbA1c, cumulative exposure to high HbA1c and high HbA1c variability had a higher risk of LREs. Among patients with baseline HbA1c ≥9%, a rapid decreasing HbA1c trajectory was associated with a lower risk of LREs, with no statistically significant difference compared to patients whose baseline HbA1c was <7% and had a mild decreasing HbA1c trajectory, while those with baseline HbA1c ≥9% and mild decreasing or increasing HbA1c trajectories were at increased risk of LREs. These findings suggest that achieving rapid glycaemic improvement after T2DM diagnosis may reduce the risk of LREs, while patients who follow mild decreasing or increasing HbA1c trajectories may benefit from closer monitoring and more intensive intervention.
引用
- Peng N, Song SJ, Wang MY, et al. HbA1c trajectories and the risk of liver-related events in patients with type 2 diabetes mellitus. J Hepatol. 2026. PMID: 42362059. doi:10.1016/j.jhep.2026.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。